Concord Wealth Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-123
Closed -$10.1K 418
2025
Q4
$10.1K Buy
123
+84
+215% +$6.54K ﹤0.01% 537
2025
Q3
$2.93K Sell
39
-84
-68% -$6.26K ﹤0.01% 683
2025
Q2
$9.13K Buy
123
+63
+105% +$4.39K ﹤0.01% 553
2025
Q1
$4.85K Sell
60
-35
-37% -$3.01K ﹤0.01% 589
2024
Q4
$7.44K Sell
95
-114
-55% -$9.69K ﹤0.01% 552
2024
Q3
$19.6K Buy
209
+82
+65% +$6.88K ﹤0.01% 473
2024
Q2
$9.91K Sell
127
-78
-38% -$6.36K ﹤0.01% 509
2024
Q1
$18.7K Sell
205
-142
-41% -$11.8K ﹤0.01% 496
2023
Q4
$26.9K Buy
347
+21
+6% +$1.47K 0.01% 442
2023
Q3
$22.2K Buy
326
+55
+20% +$4K ﹤0.01% 493
2023
Q2
$22K Buy
271
+24
+10% +$1.92K ﹤0.01% 492
2023
Q1
$20.3K Buy
+247
New +$17.6K 0.01% 491

Other funds holding GEHC

Concord Wealth Partners's GEHC Position: Q1 2026 in Review

Concord Wealth Partners sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 123 shares — an estimated $10.1K sold.

Concord Wealth Partners first reported a position in GEHC in Q1 2023 and held it in 12 quarters. The position peaked at $26.9K in Q4 2023. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Concord Wealth Partners reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Concord Wealth Partners sold 123 GE HealthCare shares in Q1 2026, an estimated $10.1K.
  • Concord Wealth Partners first reported a position in GE HealthCare in Q1 2023 and held it in 12 quarters.
  • Concord Wealth Partners's GE HealthCare position peaked at $26.9K in Q4 2023.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Concord Wealth Partners's 13F filing for Q1 2026, filed 1 May 2026.